Fluorescence immunochromatographic assay and kit for quantitative detection of creatine kinase isoenzyme (CK-MB)
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- SHENZHEN KANGMEI BIOTECH
- Publication Date
- 2012-06-27
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medical testing, in particular to a fluorescent immunochromatographic method for quantitatively detecting acute myocardial infarction marker creatine kinase isoenzyme and a kit thereof. Background technique
[0002] At present, cardiovascular disease has become the largest potential killer of adults worldwide. In the United States alone, more than 70 million people suffer from heart disease, and about 6 million people go to the emergency room due to chest pain every year. Acute myocardial infarction ( The death toll of AMI) has exceeded 500,000. In my country, the prevalence, incidence and risk factors of cardiovascular diseases are on the rise. According to statistics in recent years, the mortality rate of cardiovascular disease accounts for 40% of the population deaths, which is higher than that of European and American countries, and belongs to the country with high incidence of cardiovascular disease. Therefore...